A small RNA of Bacillus subtilis bacteriophage +29 is shown to have a novel and essential role in viral DNA packaging in vitro. This requirement for RNA in the encapsidation of viral DNA provides a new dimension of complexity to the attendant protein-DNA interactions.
into which the 18-kilobase pair (kbp) 4+29 DNA-gene product 3 complex (DNA-gp3) is packaged during morphogenesis. This finding may have general significance because common mechanisms are used in packaging double-stranded DNAs of the tailed bacteriophages (3) . In addition, the observation increases an awareness that molecules other than proteins may be involved in the assembly of DNA viruses. Indeed,, this role for RNA as a transient structural component and possible catalyst in viral morphogenesis extends the evolvement of novel and multiple biochemical functions for RNA.
An advantage of 4)29 for studies on the mechanism of DNA packaging is that genome encapsidation occurs efficiently in vitro in extracts of phage-infected cells (4) (5) (6) (7) (8) or in an adenosine triphosphate (ATP)-dependent, completely defined reaction aided by the purified gene product 16 (gpl6) (9) . Using these systems, we show below that the DNA-gp3 packaging phase of 4)29 morphogenesis is sensitive to the ribonucleases (RNases) A and Ti but that phage assembly occurs in the presence of RNase that has been treated with an RNase inhibitor (from human placenta, Boehringer Mannheim). Specifically, RNase treatment inactivates proheads by removing an RNA component. The RNA is similar to 5S rRNA in electrophoretic mobility and is shown by RNA-DNA hybridization to originate from sequences very near the left end of the viral DNA, the end packaged first during in vitro assembly (6) .
Our in vitro 4)29 assembly systems have been described (4-9). Briefly, extracts were prepared from B. subtilis SpoA12 (the sup host) infected with the suppressor-sensitive (sus) mutants susl6(300)-susl4(1241) or sus7(614)-sus8(769)-susl4(1241), which are defective in this host for production of the DNA packaging protein gpl6 or proheads, respectively. Gene product 7 (gp7) of 4)29 is the prohead scaffold, gene product 8 (gp8) is the major shell protein, and the mutation susl4(1241) provides increased yields of proteins by delaying lysis. Extracts derived from infections of the sup-(nonpermissive) bacterial host with the 16-14-and 7-8-14-mutants are designated "prohead donor" and "gpl6 donor" extracts, respectively. Exogenous [3H]DNA-gp3 can be packaged in a mixture of these extracts on an equal basis with endogenous 4)29 DNA and appear in filled heads that are separated from unpackaged DNA by sucrose gradient centrifugation. The gp3 of DNA-gp3 is covalently attached to the 5' ends of the DNA and functions both as a primer for DNA replication (10) and as an essential component in packaging (6). The completely defined in vitro packaging system includes purified DNA-gp3, proheads, and gpl6 in a reaction that requires ATP (9) . To initiate packaging in the defined system, gpl6 first binds to, and is modified by, the prohead. The prohead-gpI6 complex then binds DNA-gp3, resulting in a second conformational change in gpl6 that permits trapping and hydrolysis of ATP (11) . Packaging of the 18-kbp genome consumes 9 x 103 ATP molecules, or one ATP per 2 bp of DNA. The gpl6 protein is a prohead-dependent and DNA-gp3-dependent adenosinetriphosphatase (ATPase) that contains both Aand B-type ATP-binding consensus sequences and a potential magnesium-binding domain (12) . The efficiency of 4)29 DNA-gp3 packaging in vitro, both in extracts and in the defined system, approaches in vivo assembly (4) (5) (6) (7) (8) (9) .
RNases inhibited +29 assembly in extracts and in the defined in vitro system. Assembly of 4)29 in extracts was sensitive to treatment with the RNases Ti or A (Tables 1 and 2 Table 2 ), indicating that the inhibition of assembly was due specifically to the action of RNase rather than another contaminating enzyme. The RNases were boiled for 10 minutes before use and had no degradative effect on 4)29 DNA, as described below. were assembled by mixing a prohead donor extract with a gpl6 donor extract or by replacing the prohead donor extract with purified proheads. Prior to complementation, individual extracts or purified proheads (10 ,ul) were treated with RNase (3 ,ul) to give the indicated concentrations; after 20 minutes at room temperature, complementation mixtures were made and incubated for 90 minutes at room temperature. Assembly was measured as the number of plaque-forming units (pfu) per milliliter. Experiments represent separate complementations, each with quadruple platings, with the same components. The background was determined by complementing DNase I-treated extracts (10 pg/mi for 20 minutes) or by replacing purified proheads with TMS for complementation. Growth of bacteria, phage infections, and extract preparation have been described (4, 9) . Briefly, to prepare extracts, infected cells (2 x packaged to give filled heads that are isolated by sucrose gradient centrifuigation (9 (Fig. 1) . The data of Fig. 1 A small viral RNA copurified with the prohead. The 4)29 proheads, purified from extracts treated with DNase I (10 ,ug/ml) (see legend to Table 1 for prohead purification), were examined directly for RNA content by electrophoresis in a 1 percent agarose gel. Without prior treatment, the proheads released nucleic acid approximately the size of the 5S rRNA standard. Release of the nucleic acid from 4)29 proheads during electrophoresis in trisborate-EDTA buffer, pH 8.3, resembles RNA escape from plant viruses under alkaline conditions or in the absence of Ca2+, Mg2+, or KC1 (14) . The size of the prohead nuleic acid was confirmed by electrophoresis in a 10 percent polyacrylamide gel in the presence ofthe RNase inhibitor diethyl pyrocarbonate (Fig. 2A) . Again, the bulk of the Table 4 . Reconstruction of RNA-free proheads with purified prohead RNA. The gpl6 donor extract was treated with RNase A (0.4 ,ug/ml, 10 minutes, room temperature) and then with RNase inhibitor (from human placenta; 400 units/ml, 10 minutes, room temperature). The complementation procedures are described in the legends of Tables 1 and 2 prohead nucleic acid had a mobility similar to the 120-nucleotide 5S rRNA (compare lanes b and c). The faster band in the 5S rRNA standard was due to secondary structure, since glyoxal-treated 5S rRNA ran at the position of the prohead RNA as a single band. Proheads treated with RNase A at 10 ,ug/ml for 30 minutes at room temperature showed no bands (lane a), confirming that the prohead nucleic acid was RNA. The boiled RNase A used in this experiment had no effect on 4)29 DNA, nor did RNase Ti (Fig. 2B ).
The RNA in purified proheads was quantified by analyzing prohead concentration by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and prohead RNA concentration by PAGE. The head-to-neck connector of the 4)29 particle is a dodecamer of gene product 10 (gplO) (15) , and bands of this protein stained with Coomassie blue were compared by densitometry to stained bands of a bovine serum albumin standard. Similarly, bands of prohead RNA stained with ethidium bromide were compared to stained bands of the 5S rRNA standard. If the bulk of the proheads contained RNA, each particle had approximately two copies.
The prohead RNA was a transcript from the left end of 4)29 with RNase A and then with RNase inhibitor (Table 4 , item b). Purified RNA alone did not increase phage production (Table 4 , item c). However, the inactive RNA-free proheads and the purified prohead RNA can be reconstructed, resulting in phage production (Table 4 , item d), albeit at a relatively low efficiency compared to complementations of normal extracts and proheads (Tables 1 and  2 ). It is not clear whether this lower efficiency of assembly is due to alteration of the extracts with RNase and RNase inhibitor treatment or the quality of the purified RNA or RNA-free proheads.
In conclusion, we have demonstrated that a small RNA transcript of about 120 nucleotides from the far left end of the 4)29 genome was a component of the 4)29 prohead and that it had an essential role in 4)29 DNA packaging in vitro. Some data have been obtained for systematic investigations ofthe possible role or roles ofthe small RNA in the initiation events of DNA-gp3 packaging (11) and the formation of the prohead-dependent and DNA-gp3-dependent ATPase (12) (as mentioned earlier). Treated proheads do not produce the aggregated forms of DNA-gp3 (Fig. 1) , which are correlated with packaging efficiency (11) , suggesting that an initiation step in DNA-gp3 packaging is blocked.
Bacterial Resistance to -Lactam Antibiotics: biological world, and relatively lowly life forms often exhibit a surprising degree of sophistication in these matters. One such system that has been used to advantage by man is the defense that some fungi mount, through the production of Ilactam antibiotics, against bacterial attack. These compounds kill bacterial cells by irreversibly inhibiting a number of enzymes concemed with cell wall synthesis and repair (1) . A degree of complexity is added by the ability of some bacteria to defeat this fungal defense mechanism, primarily through the production of 69 catalytic residue Ser70 at the amino terminus of a buried helix. Examination of the disposition of the functionally important residues within the active site depression leads to a model for the binding of a substrate and a functional analogy to the serine proteases. The unusual topology of the secondary structure units is relevant to questions concerning the evolutionary relation to the I-lactam target enzymes of the bacterial cell wall.
membrane-bound and excreted enzymes which hydrolyze ,B-lactam rings. These enzymes are known as 1-lactamases or penicillinases (E.C. 3.5.2.6) (2) . A variety of ,-lactams are produced by fungi, and in tumm, there are at least three different classes of 1-lactamases produced by bacteria (3) . A further layer of complexity is provided by the production of inhibitors of 3-lactamases by some fungi (4) .
